Somalogic stock.

See the latest SomaLogic Inc Class A stock price (SLGC:XNAS), related news, valuation, dividends and more to help you make your investing decisions.The investor owns 7.01% of the outstanding SomaLogic stock. The first SomaLogic trade was made in Q3 2021. Since then Cathie Wood bought shares six more times and sold shares on two occasions. The investor's estimated purchase price is $49.9 Million, resulting in a loss of 28%. Avg closing price. Price range. Increased shares by 2.3% (+289 …Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and affiliated investment funds, have entered into voting agreements in support of the transaction. Full 2023 Year OutlookRevenue for the 3 months ended September 30, 2023, was $22 million as compared to $41.7 million in the third quarter of 2022, a 47% year-over-year decline on a GAAP basis. Excluding $22.3 million ...

IPO & Stock Price. Edit IPO & Stock Price Section. SomaLogic is registered under the ticker FRA:76X0 . Stock Symbol FRA:76X0 ; IPO Date Sep 10, 2021; Stock chart by . Investors. ... SomaLogic has a post-money valuation in the range of $1B to $10B as of Jan 4, 2018, according to PrivCo.IPO & Stock Price. Edit IPO & Stock Price Section. SomaLogic is registered under the ticker FRA:76X0 . Stock Symbol FRA:76X0 ; IPO Date Sep 10, 2021; Stock chart by . Investors. ... SomaLogic has a post-money valuation in the range of $1B to $10B as of Jan 4, 2018, according to PrivCo.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

6 oct 2023 ... Investors in Colorado-based SomaLogic meanwhile will receive 1.11 shares of Standard BioTools stock for each share they own and will post ...See the latest SomaLogic Inc Class A stock price (SLGC:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Endpoints News — SomaLogic, co-founder of acquired company battle in court over unvested stock News • Jun 29, 2023 Benzinga — Analyst Ratings for Concentrix

BOULDER, Colo., April 20, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that it will report financial results for the first quarter 2023 after market ...

Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and affiliated investment funds, have entered into voting agreements in support of the transaction. Full 2023 Year Outlook

Planned merger with SomaLogic activates strategic M&A thesis. SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- BioTools Inc. (“SBI” or the “Company”) (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today reported financial results for the third quarter …All earnings call transcripts on SomaLogic, Inc. (SLGC) stock. Read or listen to the conference call. Download the investor presentation - earnings call ...Sep 22, 2023 · 3. SomaLogic. Wood first bought shares of SomaLogic (SLGC 3.44%) last year for her Ark Genomic Revolution ETF. The ETF added to its position in the biotech stock earlier this month and now owns ... The current consensus among the four polled investment analysts is to buy stock in Somalogic Inc. This rating has remained steady since January, indicating a consistent positive outlook for the company’s performance. Somalogic Inc reported earnings per share of -$0.13 for the current quarter, suggesting a loss during this period.Information on stock, financials, earnings, subsidiaries, investors, and executives for SomaLogic. Use the PitchBook Platform to explore the full profile.SomaLogic will host a conference call at 4:30 p.m. ET on Thursday, May 12, 2022, to discuss its first quarter 2022 financial results. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding at March 31, ...21 ago 2023 ... Shane Bowen. (Id. ¶ 35.) As required by the parties' agreements, SomaLogic paid Dr. Gopinath his portion of the Upfront Stock Consideration upon ...

Shares of SomaLogic (SLGC-0.35%) ... The healthcare stock is down more than 9% this year. The move was considerable considering the stock was trading at $1.99 a share on Monday, just a penny above ...Market Cap. $464.54M. Enterprise Value -$9.65M. Total Cash (Recent Filing) $474.19M. Total Debt (Recent Filing) $0.00. Price to Earnings (P/E) -3.5. Beta 1.92. Next Earnings. Mar 26, 2024.SomaLogic Reports Second Quarter 2022 Financial Results. August 15, 2022 at 4:05 PM EDT. PDF Version. Second quarter 2022 revenue of $14.1 million, bringing year to date revenue to $37.1 million. Reducing 2022 revenue guidance to $80-90 million to account for ongoing variability in core service business, macroeconomic and commercial factors.SomaLogic Inc (NASDAQ: SLGC)’s stock price has gone rise by 4.09 in comparison to its previous close of 2.20, however, the company has experienced a 5.77% increase in its stock price over the last five trading days. GlobeNewsWire reported 2023-10-31 that BOULDER, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) — SomaLogic, Inc., a leader in proteomics […]EBITDA Margin. -. -. -167.22%. Created with Highstock 2.1.8. SomaLogic Inc. Annual stock financials by MarketWatch. View the latest SLGC financial statements, income statements and financial ratios.Oct 4, 2023 · Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and ...

SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold …Dec 1, 2023 · SomaLogic last released its earnings results on November 8th, 2023. The reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.17) by $0.05. The firm had revenue of $22.05 million for the quarter, compared to analysts' expectations of $20.45 million. SomaLogic has generated ($0.69) earnings per share over the last year ...

Track SomaLogic Inc - Ordinary Shares - Class A (SLGC) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsSomaLogic, Inc. entered into a definitive agreement to acquire to acquire Standard BioTools Inc. from Viking Global Opportunities Illiquid Investments Sub-Master LP and Viking Global Opportunities...Track SomaLogic Inc - Ordinary Shares - Class A (SLGC) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Their SLGC share price targets range from $2.30 to $7.00. On average, they expect the company's share price to reach $4.26 in the next year. This suggests a …The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.View the latest SomaLogic Inc. (SLGC) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, …

Historical daily share price chart and data for SomaLogic since 2021 adjusted for splits and dividends. The latest closing stock price for SomaLogic as of November 29, 2023 is …

SomaLogic is a community of people with diverse expertise but a singular purpose — to foster the discovery of new, effective and safer treatments for patients while empowering more accurate diagnosis, prevention and treatment of disease through the next generation of proteomics. Our team of world-class scientists, directors and administrators ...Sep 25, 2023 · The current consensus among the four polled investment analysts is to buy stock in Somalogic Inc. This rating has remained steady since January, indicating a consistent positive outlook for the company’s performance. Somalogic Inc reported earnings per share of -$0.13 for the current quarter, suggesting a loss during this period. Get the latest Somalogic Inc (SLGC) stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the …What is the target price for SomaLogic (SLGC) stock? The latest price target for SomaLogic ( NASDAQ: SLGC) was reported by Jefferies on Thursday, October 5, 2023. The analyst firm set a price ... Ark Investment Management has been accumulating the stock recently and owns 3.1% of SomaLogic stock. The current market cap of the company is $2.03B and the enterprise value is $1.8B. Over a long ...common stock and SomaLogic preferred stock held in SomaLogic’s treasury or owned by the Company, Merger Sub or SomaLogic immediately prior to the Effective Time (each an “E x c l ude d Share”), will be cancelled and no consideration will be paid or payable with respect thereto and (ii) each share of SomaLogic stock, other thanView the latest SomaLogic Inc. (SLGC) stock price, news, historical charts, analyst ratings and financial information from WSJ.SomaLogic (Nasdaq: SLGC) is fostering the discovery of effective and safer treatments for patients in need while empowering more accurate diagnosis, prevention, and treatment of disease through the next generation of proteomics. Powered by an industry-leading technology platform comprised of both assay services and diagnostics in combination ...

Under the terms of the merger agreement, SomaLogic will pay at closing $35 million, comprising $14 million in cash and $21 million in SomaLogic common stock. Up to an additional $17.5 million may be paid in connection with the achievement of certain future revenue-based milestones.The average price point forecasted by analysts for SomaLogic Inc (SLGC) is $4.70, which is $2.18 above the current market price. The public float for SLGC is 152.97M, and currently, short sellers hold a 5.10% ratio of that floaft. The average trading volume of SLGC on November 15, 2023 was 1.50M shares. Top 5 AI Stocks to Buy for 2023.With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.SomaLogic Stock Earnings. The value each SLGC share was expected to gain vs. the value that each SLGC share actually gained. SomaLogic ( SLGC) reported Q2 2023 earnings per share (EPS) of -$0.13, beating estimates of -$0.14 by 6.95%. In the same quarter last year, SomaLogic 's earnings per share (EPS) was -$0.13.Instagram:https://instagram. money market mutual funds ratesbest small cap etfstock trading computerlennar homes resale value Track SomaLogic Inc - Ordinary Shares - Class A (SLGC) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors automated data processing stockdrilling rig companies Oct 4, 2023 · SomaLogic is a leading commercial-stage proteomics company. On October 4, 2023, Standard BioTools and SomaLogic announced a merger whereby Standard BioTools will issue new shares of stock to existing SomaLogic shareholders. After the merger, which is expected to close in early 2024, current Standard BioTools shareholders will own 43% of the ... Nov 8, 2023 · SomaLogic expects revenue for the full year 2023 to range from $82 to $85 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Wednesday, November ... pioneer natural resources co stock Headline. SomaLogic Inc Class A. morningstar.com - November 22 at 6:40 PM. With 54% ownership of the shares, SomaLogic, Inc. (NASDAQ:SLGC) is heavily dominated by institutional owners. finance.yahoo.com - November 22 at 1:39 PM. SomaLogic, Inc. (NASDAQ:SLGC) Q3 2023 Earnings Call Transcript. …Somalogic story: Study finds proteomic risk scores for cardiovascular disease from SomaSignal Cardio DM tests could support physicians in managing patient outcomes and other headlines for Somalogic Stock